Blood, 1 June 2002, Vol. 99, No. 11, pp. 3915-3915
ERRATUM
In the article by Rajvanshi et al entitled "Hepatic
sinusoidal obstruction after gemtuzumab ozogamicin (Mylotarg)
therapy," which appeared in the April 1, 2002, issue of
Blood (Volume 99:2310-2314), the last sentence in the first
paragraph of "Introduction" incorrectly states the order of
administration of gemtuzumab ozogamicin. The sentence should read,
"In patients administered gemtuzumab ozogamicin followed by
myeloablative therapy and hematopoietic cell transplantation, the
reported frequency of posttransplantation clinical illness resembling
veno-occlusive disease of the liver was 6 of 38 (16%) and included 3 fatalities (Sievers et al7 and unpublished observations
[March 2001], Wyeth-Ayerst Pharmaceuticals)."
